# Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma

> **NCT05563012** · PHASE2 · RECRUITING · sponsor: **Renmin Hospital of Wuhan University** · enrollment: 29 (estimated)

## Conditions studied

- Disorder in Complete Remission in Response to Treatment

## Interventions

- **DRUG:** Sintilimal Injection

## Key facts

- **NCT ID:** NCT05563012
- **Lead sponsor:** Renmin Hospital of Wuhan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-26
- **Primary completion:** 2025-10-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2022-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05563012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05563012, "Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05563012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*